{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T20:43:13Z","timestamp":1770842593156,"version":"3.50.1"},"reference-count":44,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T00:00:00Z","timestamp":1738800000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Leber\u2019s hereditary optic neuropathy (LHON) is the most common mitochondrial disease, and was the first to be linked to mitochondrial DNA (mtDNA) variations. Recently, autosomal recessive forms of LHON were described in addition to the classical mtDNA-associated forms. Clinically, LHON manifests with subacute and painless loss of central visual acuity, in most cases starting unilaterally, and involving the second eye a few weeks later. Almost all LHON cases are caused by pathogenic variants in genes that code for proteins relevant for function of Complex\u00a0I of the respiratory chain. The Complex\u00a0I dysfunction in LHON leads to decreased ATP synthesis and to increased production of reactive oxygen species which ultimately initiates dysfunction and apoptosis of retinal ganglion cells and their axons, the optic nerve. Idebenone, a synthetic CoQ derivative, is a potent intramitochondrial antioxidant and can shuttle electrons directly to complex III of the respiratory chain, thereby bypassing complex I deficiency. On the basis of several clinical trials, it has been approved as a treatment for LHON in 2015 (in the EU). In addition, direct intravitreal gene replacement therapy is being investigated, with several late-stage clinical trials already completed. In the future, gene editing of mtDNA variants may also become a therapeutic option.<\/jats:p>","DOI":"10.1515\/medgen-2024-2066","type":"journal-article","created":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T08:49:51Z","timestamp":1739263791000},"page":"57-63","source":"Crossref","is-referenced-by-count":3,"title":["Leber\u2019s hereditary optic neuropathy\u00a0\u2013 current status of idebenone and gene replacement therapies"],"prefix":"10.1515","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2805-4652","authenticated-orcid":false,"suffix":"FEAN","given":"Thomas","family":"Klopstock","sequence":"first","affiliation":[{"name":"LMU Munich Friedrich Baur Institute at the Department of Neurology, LMU University Hospital Ziemssenstr. 1 Munich Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1642-6447","authenticated-orcid":false,"given":"Leopold H.","family":"Zeng","sequence":"additional","affiliation":[{"name":"LMU Munich Friedrich Baur Institute at the Department of Neurology, LMU University Hospital Ziemssenstr. 1 Munich Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1847-3626","authenticated-orcid":false,"suffix":"FEBO","given":"Claudia","family":"Priglinger","sequence":"additional","affiliation":[{"name":"LMU Munich Department of Ophthalmology, LMU University Hospital Mathildenstr. 8 Munich Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2025,2,12]]},"reference":[{"key":"2025121816443123185_j_medgen-2024-2066_ref_001","doi-asserted-by":"crossref","unstructured":"Yu-Wai-Man P, Griffiths PG, Brown DT, Howell N, Turnbull DM, Chinnery PF (2003) The epidemiology of Leber hereditary optic neuropathy in the North East of England. Am J Hum Genet;72(2):333\u20139.","DOI":"10.1086\/346066"},{"key":"2025121816443123185_j_medgen-2024-2066_ref_002","doi-asserted-by":"crossref","unstructured":"Puomila A, H\u00e4m\u00e4l\u00e4inen P, Kivioja S, Savontaus M-L, Koivum\u00e4ki S, Huoponen K, Nikoskelainen E (2007) Epidemiology and penetrance of Leber hereditary optic neuropathy in Finland. European Journal of Human Genetics;15(10):1079\u201389.","DOI":"10.1038\/sj.ejhg.5201828"},{"key":"2025121816443123185_j_medgen-2024-2066_ref_003","doi-asserted-by":"crossref","unstructured":"Leber T (1871) Ueber heredit\u00e4re und congenital-angelegte Sehnervenleiden. Albrecht von Graefes Archiv f\u00fcr Ophthalmologie;17(2):249\u201391.","DOI":"10.1007\/BF01694557"},{"key":"2025121816443123185_j_medgen-2024-2066_ref_004","doi-asserted-by":"crossref","unstructured":"Wallace DC, Singh G, Lott MT, Hodge JA, Schurr TG, Lezza AMS, Elsas LJ, Nikoskelainen EK (1988) Mitochondrial DNA Mutation Associated with Leber\u2019s Hereditary Optic Neuropathy. Science;242(4884):1427\u201330.","DOI":"10.1126\/science.3201231"},{"key":"2025121816443123185_j_medgen-2024-2066_ref_005","doi-asserted-by":"crossref","unstructured":"Amore G, Romagnoli M, Carbonelli M, Barboni P, Carelli V, La Morgia C (2021) Therapeutic Options in Hereditary Optic Neuropathies. Drugs;81(1):57\u201386.","DOI":"10.1007\/s40265-020-01428-3"},{"key":"2025121816443123185_j_medgen-2024-2066_ref_006","doi-asserted-by":"crossref","unstructured":"Shamsnajafabadi H, MacLaren RE, Cehajic-Kapetanovic J (2023) Current and Future Landscape in Genetic Therapies for Leber Hereditary Optic Neuropathy. Cells;12(15).","DOI":"10.3390\/cells12152013"},{"key":"2025121816443123185_j_medgen-2024-2066_ref_007","doi-asserted-by":"crossref","unstructured":"Kirkman MA, Yu-Wai-Man P, Korsten A, Leonhardt M, Dimitriadis K, De Coo IF, Klopstock T, Chinnery PF (2009) Gene-environment interactions in Leber hereditary optic neuropathy. Brain;132(Pt 9):2317\u201326.","DOI":"10.1093\/brain\/awp158"},{"key":"2025121816443123185_j_medgen-2024-2066_ref_008","unstructured":"Newman NJ, Yu-Wai-Man P, Subramanian PS, Moster ML, Wang AG, Donahue SP, Leroy BP, Carelli V, Biousse V, Vignal-Clermont C, Sergott RC, Sadun AA, Rebolleda Fern\u00e1ndez G, Chwalisz BK, Banik R, Bazin F, Roux M, Cox ED, Taiel M, Sahel JA (2023) Randomized trial of bilateral gene therapy injection for m.11778G>A MT-ND4 Leber optic neuropathy. Brain;146(4):1328\u201341."},{"key":"2025121816443123185_j_medgen-2024-2066_ref_009","doi-asserted-by":"crossref","unstructured":"Kirkman MA, Korsten A, Leonhardt M, Dimitriadis K, De Coo IF, Klopstock T, Griffiths PG, Hudson G, Chinnery PF, Yu-Wai-Man P (2009) Quality of Life in Patients with Leber Hereditary Optic Neuropathy. Investigative Ophthalmology & Visual Science;50(7):3112\u20135.","DOI":"10.1167\/iovs.08-3166"},{"key":"2025121816443123185_j_medgen-2024-2066_ref_010","doi-asserted-by":"crossref","unstructured":"Baglivo M, Nasca A, Lamantea E, Vinci S, Spagnolo M, Marchet S, Prokisch H, Catania A, Lamperti C, Ghezzi D (2023) Evaluation of Mitochondrial Dysfunction and Idebenone Responsiveness in Fibroblasts from Leber\u2019s Hereditary Optic Neuropathy (LHON) Subjects. Int J Mol Sci;24(16).","DOI":"10.3390\/ijms241612580"},{"key":"2025121816443123185_j_medgen-2024-2066_ref_011","doi-asserted-by":"crossref","unstructured":"Lopez Sanchez MIG, Kearns LS, Staffieri SE, Clarke L, McGuinness MB, Meteoukki W, Samuel S, Ruddle JB, Chen C, Fraser CL, Harrison J, Hewitt AW, Howell N, Mackey DA (2021) Establishing risk of vision loss in Leber hereditary optic neuropathy. Am J Hum Genet;108(11):2159\u201370.","DOI":"10.1016\/j.ajhg.2021.09.015"},{"key":"2025121816443123185_j_medgen-2024-2066_ref_012","doi-asserted-by":"crossref","unstructured":"Lenaers G, Beaulieu C, Charif M, Gerber S, Kaplan J, Rozet JM (2023) Autosomal recessive Leber hereditary optic neuropathy, a new neuro-ophthalmo-genetic paradigm. Brain;146(8):3156\u201361.","DOI":"10.1093\/brain\/awad131"},{"key":"2025121816443123185_j_medgen-2024-2066_ref_013","doi-asserted-by":"crossref","unstructured":"Stenton SL, Sheremet NL, Catarino CB, Andreeva NA, Assouline Z, Barboni P, Barel O, Berutti R, Bychkov I, Caporali L, Capristo M, Carbonelli M, Cascavilla ML, Charbel Issa P, Freisinger P, Gerber S, Ghezzi D, Graf E, Heidler J, Hempel M, Heon E, Itkis YS, Javasky E, Kaplan J, Kopajtich R, Kornblum C, Kovacs-Nagy R, Krylova TD, Kunz WS, La Morgia C, Lamperti C, Ludwig C, Malacarne PF, Maresca A, Mayr JA, Meisterknecht J, Nevinitsyna TA, Palombo F, Pode-Shakked B, Shmelkova MS, Strom TM, Tagliavini F, Tzadok M, van der Ven AT, Vignal-Clermont C, Wagner M, Zakharova EY, Zhorzholadze NV, Rozet JM, Carelli V, Tsygankova PG, Klopstock T, Wittig I, Prokisch H (2021) Impaired complex I repair causes recessive Leber\u2019s hereditary optic neuropathy. J Clin Invest;131(6).","DOI":"10.1172\/JCI138267"},{"key":"2025121816443123185_j_medgen-2024-2066_ref_014","doi-asserted-by":"crossref","unstructured":"Kieninger S, Xiao T, Weisschuh N, Kohl S, R\u00fcther K, Kroisel PM, Brockmann T, Knappe S, Kellner U, Lagr\u00e8ze W, Mazzola P, Haack TB, Wissinger B, Tonagel F (2022) DNAJC30 disease-causing gene variants in a large Central European cohort of patients with suspected Leber\u2019s hereditary optic neuropathy and optic atrophy. J Med Genet;59(10):1027\u201334.","DOI":"10.1136\/jmedgenet-2021-108235"},{"key":"2025121816443123185_j_medgen-2024-2066_ref_015","doi-asserted-by":"crossref","unstructured":"Gerber S, Ding MG, G\u00e9rard X, Zwicker K, Zanlonghi X, Rio M, Serre V, Hanein S, Munnich A, Rotig A, Bianchi L, Amati-Bonneau P, Elpeleg O, Kaplan J, Brandt U, Rozet J-M (2017) Compound heterozygosity for severe and hypomorphic <em>NDUFS2<\/em> mutations cause non-syndromic LHON-like optic neuropathy. Journal of Medical Genetics;54(5):346\u201356.","DOI":"10.1136\/jmedgenet-2016-104212"},{"key":"2025121816443123185_j_medgen-2024-2066_ref_016","doi-asserted-by":"crossref","unstructured":"Poincenot L, Pearson AL, Karanjia R (2020) Demographics of a Large International Population of Patients Affected by Leber\u2019s Hereditary Optic Neuropathy. Ophthalmology;127(5):679\u201388.","DOI":"10.1016\/j.ophtha.2019.11.014"},{"key":"2025121816443123185_j_medgen-2024-2066_ref_017","doi-asserted-by":"crossref","unstructured":"Skorczyk-Werner A, To\u0144ska K, Maciejczuk A, Nowomiejska K, Korwin M, O\u0142dak M, Wawrocka A, Krawczy\u0144ski MR (2023) DNAJC30 Gene Variants Are a Frequent Cause of a Rare Disease: Leber Hereditary Optic Neuropathy in Polish Patients. Int J Mol Sci;24(24).","DOI":"10.3390\/ijms242417496"},{"key":"2025121816443123185_j_medgen-2024-2066_ref_018","doi-asserted-by":"crossref","unstructured":"Stenton SL, Tesarova M, Sheremet NL, Catarino CB, Carelli V, Ciara E, Curry K, Engvall M, Fleming LR, Freisinger P, Iwanicka-Pronicka K, Jurkiewicz E, Klopstock T, Koenig MK, Kol\u00e1\u0159ov\u00e1 H, Kousal B, Krylova T, La Morgia C, Noskov\u00e1 L, Piekutowska-Abramczuk D, Russo SN, Str\u00e1neck\u00fd V, T\u00f3thov\u00e1 I, Tr\u00e4isk F, Prokisch H (2022) DNAJC30 defect: a frequent cause of recessive Leber hereditary optic neuropathy and Leigh syndrome. Brain;145(5):1624\u201331.","DOI":"10.1093\/brain\/awac052"},{"key":"2025121816443123185_j_medgen-2024-2066_ref_019","doi-asserted-by":"crossref","unstructured":"Protasoni M, Zeviani M (2021) Mitochondrial Structure and Bioenergetics in Normal and Disease Conditions. Int J Mol Sci;22(2).","DOI":"10.3390\/ijms22020586"},{"key":"2025121816443123185_j_medgen-2024-2066_ref_020","doi-asserted-by":"crossref","unstructured":"Danielson SR, Wong A, Carelli V, Martinuzzi A, Schapira AHV, Cortopassi GA (2002) Cells Bearing Mutations Causing Leber\u2019s Hereditary Optic Neuropathy Are Sensitized to Fas-induced Apoptosis *. Journal of Biological Chemistry;277(8):5810\u20135.","DOI":"10.1074\/jbc.M110119200"},{"key":"2025121816443123185_j_medgen-2024-2066_ref_021","doi-asserted-by":"crossref","unstructured":"Zorov DB, Juhaszova M, Sollott SJ (2014) Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. Physiol Rev;94(3):909\u201350.","DOI":"10.1152\/physrev.00026.2013"},{"key":"2025121816443123185_j_medgen-2024-2066_ref_022","doi-asserted-by":"crossref","unstructured":"Erb M, Hoffmann-Enger B, Deppe H, Soeberdt M, Haefeli RH, Rummey C, Feurer A, Gueven N (2012) Features of Idebenone and Related Short-Chain Quinones that Rescue ATP Levels under Conditions of Impaired Mitochondrial Complex I. PLOS ONE;7(4):e36153.","DOI":"10.1371\/journal.pone.0036153"},{"key":"2025121816443123185_j_medgen-2024-2066_ref_023","doi-asserted-by":"crossref","unstructured":"Klopstock T, Yu-Wai-Man P, Dimitriadis K, Rouleau J, Heck S, Bailie M, Atawan A, Chattopadhyay S, Schubert M, Garip A, Kernt M, Petraki D, Rummey C, Leinonen M, Metz G, Griffiths PG, Meier T, Chinnery PF (2011) A randomized placebo-controlled trial of idebenone in Leber\u2019s hereditary optic neuropathy. Brain;134(Pt 9):2677\u201386.","DOI":"10.1093\/brain\/awr170"},{"key":"2025121816443123185_j_medgen-2024-2066_ref_024","doi-asserted-by":"crossref","unstructured":"Carelli V, La Morgia C, Valentino ML, Rizzo G, Carbonelli M, De Negri AM, Sadun F, Carta A, Guerriero S, Simonelli F, Sadun AA, Aggarwal D, Liguori R, Avoni P, Baruzzi A, Zeviani M, Montagna P, Barboni P (2011) Idebenone Treatment In Leber\u2019s Hereditary Optic Neuropathy. Brain;134(9):e188-e.","DOI":"10.1093\/brain\/awr180"},{"key":"2025121816443123185_j_medgen-2024-2066_ref_025","doi-asserted-by":"crossref","unstructured":"Catarino CB, von Livonius B, Priglinger C, Banik R, Matloob S, Tamhankar MA, Castillo L, Friedburg C, Halfpenny CA, Lincoln JA, Traber GL, Acaroglu G, Black GCM, Doncel C, Fraser CL, Jakubaszko J, Landau K, Langenegger SJ, Mu\u00f1oz-Negrete FJ, Newman NJ, Poulton J, Scoppettuolo E, Subramanian P, Toosy AT, Vidal M, Vincent AL, Votruba M, Zarowski M, Zermansky A, Lob F, Rudolph G, Mikazans O, Silva M, Ll\u00f2ria X, Metz G, Klopstock T (2020) Real-World Clinical Experience With Idebenone in the Treatment of Leber Hereditary Optic Neuropathy. J Neuroophthalmol;40(4):558\u201365.","DOI":"10.1097\/WNO.0000000000001023"},{"key":"2025121816443123185_j_medgen-2024-2066_ref_026","doi-asserted-by":"crossref","unstructured":"Yu-Wai-Man P, Carelli V, Newman NJ, Silva MJ, Linden A, Van Stavern G, Szaflik JP, Banik R, Lubi\u0144ski W, Pemp B, Liao YJ, Subramanian PS, Misiuk-Hoj\u0142o M, Newman S, Castillo L, Koci\u0119cki J, Levin MH, Mu\u00f1oz-Negrete FJ, Yagan A, Cherninkova S, Katz D, Meunier A, Votruba M, Korwin M, Dziedziak J, Jurkut\u0117 N, Harvey JP, La Morgia C, Priglinger C, Ll\u00f2ria X, Tomasso L, Klopstock T (2024) Therapeutic benefit of idebenone in patients with Leber hereditary optic neuropathy: The LEROS nonrandomized controlled trial. Cell Rep Med;5(3):101437.","DOI":"10.1016\/j.xcrm.2024.101437"},{"key":"2025121816443123185_j_medgen-2024-2066_ref_027","doi-asserted-by":"crossref","unstructured":"Varricchio C, Beirne K, Heard C, Newland B, Rozanowska M, Brancale A, Votruba M (2020) The ying and yang of idebenone: Not too little, not too much \u2013 cell death in NQO1 deficient cells and the mouse retina. Free Radical Biology and Medicine;152:551\u201360.","DOI":"10.1016\/j.freeradbiomed.2019.11.030"},{"key":"2025121816443123185_j_medgen-2024-2066_ref_028","doi-asserted-by":"crossref","unstructured":"Aleo SJ, Del Dotto V, Romagnoli M, Fiorini C, Capirossi G, Peron C, Maresca A, Caporali L, Capristo M, Tropeano CV, Zanna C, Ross-Cisneros FN, Sadun AA, Pignataro MG, Giordano C, Fasano C, Cavaliere A, Porcelli AM, Tioli G, Musiani F, Catania A, Lamperti C, Marzoli SB, De Negri A, Cascavilla ML, Battista M, Barboni P, Carbonelli M, Amore G, La Morgia C, Smirnov D, Vasilescu C, Farzeen A, Blickhaeuser B, Prokisch H, Priglinger C, Livonius B, Catarino CB, Klopstock T, Tiranti V, Carelli V, Ghelli AM (2024) Genetic variants affecting NQO1 protein levels impact the efficacy of idebenone treatment in Leber hereditary optic neuropathy. Cell Reports Medicine;5(2).","DOI":"10.1016\/j.xcrm.2023.101383"},{"key":"2025121816443123185_j_medgen-2024-2066_ref_029","doi-asserted-by":"crossref","unstructured":"van Everdingen JAM, Pott JWR, Bauer NJC, Krijnen AM, Lushchyk T, Wubbels RJ (2022) Clinical outcomes of treatment with idebenone in Leber\u2019s hereditary optic neuropathy in the Netherlands: A national cohort study. Acta Ophthalmol;100(6):700\u20136.","DOI":"10.1111\/aos.15153"},{"key":"2025121816443123185_j_medgen-2024-2066_ref_030","doi-asserted-by":"crossref","unstructured":"Cwerman-Thibault H, Augustin S, Lechauve C, Ayache J, Ellouze S, Sahel JA, Corral-Debrinski M (2015) Nuclear expression of mitochondrial ND4 leads to the protein assembling in complex I and prevents optic atrophy and visual loss. Mol Ther Methods Clin Dev;2:15003.","DOI":"10.1038\/mtm.2015.3"},{"key":"2025121816443123185_j_medgen-2024-2066_ref_031","doi-asserted-by":"crossref","unstructured":"Omura T (1998) Mitochondria-Targeting Sequence, a Multi-Role Sorting Sequence Recognized at All Steps of Protein Import into Mitochondria. The Journal of Biochemistry;123(6):1010\u20136.","DOI":"10.1093\/oxfordjournals.jbchem.a022036"},{"key":"2025121816443123185_j_medgen-2024-2066_ref_032","doi-asserted-by":"crossref","unstructured":"Newman NJ, Yu-Wai-Man P, Carelli V, Moster ML, Biousse V, Vignal-Clermont C, Sergott RC, Klopstock T, Sadun AA, Barboni P, DeBusk AA, Girmens JF, Rudolph G, Karanjia R, Taiel M, Blouin L, Smits G, Katz B, Sahel J-A, Vignal C, Hage R, Catarino CB, Priglinger C, Priglinger S, Thurau S, von Livonius B, Muth D, Wolf A, Al-Tamami J, Pressler A, Schertler C, Hildebrandt M, Neuenhahn M, Heilweil G, Tsui I, Hubbard GB, Hendrick A, Dattilo M, Peragallo J, Hawy E, DuBois, Med L, Gibbs D, Filho AF, Dobbs J, Carbonelli M, Di Vito L, Contin M, Mohamed S, La Morgia C, Silvestri S, Acheson J, Eleftheriadou M, Esposti S, Gemenetzi M, Leitch-Devlin L, Tucker WR, Jurkute N, SantaMaria M, Tollis H, Haller JA, Massini M (2021) Efficacy and Safety of Intravitreal Gene Therapy for Leber Hereditary Optic Neuropathy Treated within 6 Months of Disease Onset. Ophthalmology;128(5):649\u201360.","DOI":"10.1016\/j.ophtha.2020.12.012"},{"key":"2025121816443123185_j_medgen-2024-2066_ref_033","doi-asserted-by":"crossref","unstructured":"Yu-Wai-Man P, Newman NJ, Carelli V, Moster ML, Biousse V, Sadun AA, Klopstock T, Vignal-Clermont C, Sergott RC, Rudolph G, La Morgia C, Karanjia R, Taiel M, Blouin L, Burgui\u00e8re P, Smits G, Chevalier C, Masonson H, Salermo Y, Katz B, Picaud S, Calkins DJ, Sahel J-A (2020) Bilateral visual improvement with unilateral gene therapy injection for Leber hereditary optic neuropathy. Science Translational Medicine;12(573):eaaz7423.","DOI":"10.1126\/scitranslmed.aaz7423"},{"key":"2025121816443123185_j_medgen-2024-2066_ref_034","doi-asserted-by":"crossref","unstructured":"Feuer WJ, Schiffman JC, Davis JL, Porciatti V, Gonzalez P, Koilkonda RD, Yuan H, Lalwani A, Lam BL, Guy J (2016) Gene Therapy for Leber Hereditary Optic Neuropathy: Initial Results. Ophthalmology;123(3):558\u201370.","DOI":"10.1016\/j.ophtha.2015.10.025"},{"key":"2025121816443123185_j_medgen-2024-2066_ref_035","doi-asserted-by":"crossref","unstructured":"Guy J, Feuer WJ, Davis JL, Porciatti V, Gonzalez PJ, Koilkonda RD, Yuan H, Hauswirth WW, Lam BL (2017) Gene Therapy for Leber Hereditary Optic Neuropathy: Low- and Medium-Dose Visual Results. Ophthalmology;124(11):1621\u201334.","DOI":"10.1016\/j.ophtha.2017.05.016"},{"key":"2025121816443123185_j_medgen-2024-2066_ref_036","doi-asserted-by":"crossref","unstructured":"Lam BL, Feuer WJ, Davis JL, Porciatti V, Yu H, Levy RB, Vanner E, Guy J (2022) Leber Hereditary Optic Neuropathy Gene Therapy: Adverse Events and Visual Acuity Results of All Patient Groups. Am J Ophthalmol;241:262\u201371.","DOI":"10.1016\/j.ajo.2022.02.023"},{"key":"2025121816443123185_j_medgen-2024-2066_ref_037","doi-asserted-by":"crossref","unstructured":"Wan X, Pei H, Zhao MJ, Yang S, Hu WK, He H, Ma SQ, Zhang G, Dong XY, Chen C, Wang DW, Li B (2016) Efficacy and Safety of rAAV2-ND4 Treatment for Leber\u2019s Hereditary Optic Neuropathy. Sci Rep;6:21587.","DOI":"10.1038\/srep21587"},{"key":"2025121816443123185_j_medgen-2024-2066_ref_038","doi-asserted-by":"crossref","unstructured":"Vignal-Clermont C, Girmens JF, Audo I, Said SM, Errera MH, Plaine L, O\u2019Shaughnessy D, Taiel M, Sahel JA (2021) Safety of Intravitreal Gene Therapy for Treatment of Subjects with Leber Hereditary Optic Neuropathy due to Mutations in the Mitochondrial ND4 Gene: The REVEAL Study. BioDrugs;35(2):201\u201314.","DOI":"10.1007\/s40259-021-00468-9"},{"key":"2025121816443123185_j_medgen-2024-2066_ref_039","doi-asserted-by":"crossref","unstructured":"Biousse V, Newman NJ, Yu-Wai-Man P, Carelli V, Moster ML, Vignal-Clermont C, Klopstock T, Sadun AA, Sergott RC, Hage R, Esposti S, La Morgia C, Priglinger C, Karanja R, Blouin L, Taiel M, Sahel JA (2021) Long-Term Follow-Up After Unilateral Intravitreal Gene Therapy for Leber Hereditary Optic Neuropathy: The RESTORE Study. J Neuroophthalmol;41(3):309\u201315.","DOI":"10.1097\/WNO.0000000000001367"},{"key":"2025121816443123185_j_medgen-2024-2066_ref_040","doi-asserted-by":"crossref","unstructured":"Liu Y, Eastwood JD, Alba DE, Velmurugan S, Sun N, Porciatti V, Lee RK, Hauswirth WW, Guy J, Yu H (2022) Gene therapy restores mitochondrial function and protects retinal ganglion cells in optic neuropathy induced by a mito-targeted mutant ND1 gene. Gene Ther;29(6):368\u201378.","DOI":"10.1038\/s41434-022-00333-6"},{"key":"2025121816443123185_j_medgen-2024-2066_ref_041","doi-asserted-by":"crossref","unstructured":"Gao Y, Guo L, Wang F, Wang Y, Li P, Zhang D (2024) Development of mitochondrial gene-editing strategies and their potential applications in mitochondrial hereditary diseases: a review. Cytotherapy;26(1):11\u201324.","DOI":"10.1016\/j.jcyt.2023.10.004"},{"key":"2025121816443123185_j_medgen-2024-2066_ref_042","doi-asserted-by":"crossref","unstructured":"Mok BY, de Moraes MH, Zeng J, Bosch DE, Kotrys AV, Raguram A, Hsu F, Radey MC, Peterson SB, Mootha VK, Mougous JD, Liu DR (2020) A bacterial cytidine deaminase toxin enables CRISPR-free mitochondrial base editing. Nature;583(7817):631\u20137.","DOI":"10.1038\/s41586-020-2477-4"},{"key":"2025121816443123185_j_medgen-2024-2066_ref_043","doi-asserted-by":"crossref","unstructured":"Cho SI, Lee S, Mok YG, Lim K, Lee J, Lee JM, Chung E, Kim JS (2022) Targeted A-to-G base editing in human mitochondrial DNA with programmable deaminases. Cell;185(10):1764\u201376.e12.","DOI":"10.1016\/j.cell.2022.03.039"},{"key":"2025121816443123185_j_medgen-2024-2066_ref_044","doi-asserted-by":"crossref","unstructured":"Yi Z, Zhang X, Tang W, Yu Y, Wei X, Zhang X, Wei W (2024) Strand-selective base editing of human mitochondrial DNA using mitoBEs. Nat Biotechnol;42(3):498\u2013509.","DOI":"10.1038\/s41587-023-01791-y"}],"container-title":["Medizinische Genetik"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/medgen-2024-2066\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/medgen-2024-2066\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T16:54:56Z","timestamp":1766076896000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/medgen-2024-2066\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,6]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,2,12]]},"published-print":{"date-parts":[[2025,2,6]]}},"alternative-id":["10.1515\/medgen-2024-2066"],"URL":"https:\/\/doi.org\/10.1515\/medgen-2024-2066","relation":{},"ISSN":["1863-5490","0936-5931"],"issn-type":[{"value":"1863-5490","type":"electronic"},{"value":"0936-5931","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2,6]]}}}